90
Participants
Start Date
September 5, 2023
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2026
Seladelpar 10 mg
Administered orally
Placebo
Administered orally
New York University (NYU) Langone Medical Center, New York
Weill Cornell Medicine, New York
Northwell Health Center for Liver Disease and Transplantation, Manhasset
New-York-Presbyterian Brooklyn Methodist Hospital, Brooklyn
University of Rochester Medical Center - Strong Memorial Hospital, Rochester
UPMC Center for Liver Health, Pittsburgh
Perelman Center for Advanced Medicine, Philadelphia
Thomas Jefferson University, Philadelphia
Mercy Medical Center - Baltimore, Maryland, Baltimore
Bon Secours Liver Institute of Hampton Roads, Richmond
Digestive Healthcare of Georgia, Atlanta
University of Miami - Schiff Center for Liver Diseases, Miami
Gastro Health Research, Miami
Covenant Metabolic Specialists, LLC, Tampa
Covenant Metabolic Specialists, LLC, Sarasota
Florida Research Institute, Lakewood Rch
Galen Hepatology, Hixson
Gastrointestinal Associates of Northeast Tennessee, P.C., Johnson City
OGI - Gastro One, Cordova
Gastro Health Research, Liberty Township
Henry Ford Health System, Novi
University of Minnesota, Minneapolis
Northwestern Medicine Clinical Research Unit (CRU), Chicago
Kansas City Research Institute, Kansas City
Tulane University Medical Center, New Orleans
Louisiana Research Center, LLC, Shreveport
Soma Clinical Trials, LLC, Denison
The Liver Institute at Methodist Dallas Medical Center, Dallas
Liver Center of Texas, Dallas
University of Texas Southwestern Medical Center, Dallas
Baylor College of Medicine - Baylor Clinic, Houston
Liver Associates of Texas, P.A., Houston
American Research Corporation - San Antonio, TX, Austin
University of Colorado Denver - School of Medicine - Anschutz Medical Campus, Aurora
South Denver Gastroenterology, Englewood
The Institute for Liver Health II LLC dba Arizona Clinical Trials; Arizona Liver Health, Chandler
California Liver Research Institute, Pasadena
California Pacific Medical Center, San Francisco
University of California (UC) Davis Medical Center, Sacramento
Velocity Clinical Research - Seattle, Seattle
Stanford University, Seattle
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Centre de Recherche du Centre Hospitallier de I'Universite de Montreal (CRCHUM), Montreal
(G.I.R.I.) GI Research Institute Foundation, Vancouver
Lead Sponsor
Gilead Sciences
INDUSTRY